March 23, 2020 / 2:10 PM / 15 days ago

BRIEF-Roche Gives Update On Venclexta/Venclyxto Combination

March 23 (Reuters) - Roche Holding AG:

* ROCHE ANNOUNCES VENCLEXTA/VENCLYXTO COMBINATION IMPROVED OVERALL SURVIVAL IN PEOPLE WITH PREVIOUSLY UNTREATED ACUTE MYELOID LEUKAEMIA

* PHASE III VIALE-A STUDY SHOWED VENCLEXTA/VENCLYXTO PLUS AZACITIDINE HELPED PEOPLE WITH THE MOST COMMON TYPE OF AGGRESSIVE LEUKAEMIA IN ADULTS LIVE LONGER COMPARED TO AZACITIDINE ALONE Source textLÖ bit.ly/2y09GFn Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below